UA72443C2 - Спосіб трансформації рослин і лінія клітин ембріогенного калюсу zea mays - Google Patents
Спосіб трансформації рослин і лінія клітин ембріогенного калюсу zea mays Download PDFInfo
- Publication number
- UA72443C2 UA72443C2 UA99126545A UA99126545A UA72443C2 UA 72443 C2 UA72443 C2 UA 72443C2 UA 99126545 A UA99126545 A UA 99126545A UA 99126545 A UA99126545 A UA 99126545A UA 72443 C2 UA72443 C2 UA 72443C2
- Authority
- UA
- Ukraine
- Prior art keywords
- tissue
- gene
- plant cell
- callus
- cells
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 59
- 230000009466 transformation Effects 0.000 title abstract description 47
- 241000196324 Embryophyta Species 0.000 claims abstract description 110
- 230000017074 necrotic cell death Effects 0.000 claims abstract description 35
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 23
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 147
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 103
- 108090000623 proteins and genes Proteins 0.000 claims description 92
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 57
- 235000005822 corn Nutrition 0.000 claims description 57
- 230000000408 embryogenic effect Effects 0.000 claims description 53
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 52
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 26
- 239000013598 vector Substances 0.000 claims description 24
- 108091026890 Coding region Proteins 0.000 claims description 16
- 230000015572 biosynthetic process Effects 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 239000002773 nucleotide Substances 0.000 claims description 16
- 125000003729 nucleotide group Chemical group 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 239000003112 inhibitor Substances 0.000 claims description 15
- 239000013000 chemical inhibitor Substances 0.000 claims description 14
- 230000009261 transgenic effect Effects 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 10
- 239000005977 Ethylene Substances 0.000 claims description 10
- 210000001161 mammalian embryo Anatomy 0.000 claims description 9
- 230000004044 response Effects 0.000 claims description 9
- 241000209140 Triticum Species 0.000 claims description 8
- 235000021307 Triticum Nutrition 0.000 claims description 8
- 238000002635 electroconvulsive therapy Methods 0.000 claims description 6
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 5
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 5
- 101100062377 Caenorhabditis elegans dad-1 gene Proteins 0.000 claims description 4
- 229930191978 Gibberellin Natural products 0.000 claims description 4
- 239000005557 antagonist Substances 0.000 claims description 4
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 claims description 4
- 239000003448 gibberellin Substances 0.000 claims description 4
- 108020004999 messenger RNA Proteins 0.000 claims description 4
- 230000035939 shock Effects 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- 241000209149 Zea Species 0.000 claims 2
- 235000013339 cereals Nutrition 0.000 claims 2
- 241000209504 Poaceae Species 0.000 abstract description 2
- 230000001976 improved effect Effects 0.000 abstract description 2
- 241000589158 Agrobacterium Species 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 126
- 239000002609 medium Substances 0.000 description 107
- 210000001519 tissue Anatomy 0.000 description 106
- 240000008042 Zea mays Species 0.000 description 101
- 210000002257 embryonic structure Anatomy 0.000 description 95
- 238000011081 inoculation Methods 0.000 description 59
- 108020004414 DNA Proteins 0.000 description 52
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 46
- 235000009973 maize Nutrition 0.000 description 46
- 206010028851 Necrosis Diseases 0.000 description 33
- 230000000977 initiatory effect Effects 0.000 description 33
- 239000013612 plasmid Substances 0.000 description 33
- 230000000694 effects Effects 0.000 description 25
- 230000030833 cell death Effects 0.000 description 21
- 239000000243 solution Substances 0.000 description 19
- 239000012634 fragment Substances 0.000 description 18
- 238000013467 fragmentation Methods 0.000 description 18
- 238000006062 fragmentation reaction Methods 0.000 description 18
- 230000008929 regeneration Effects 0.000 description 18
- 238000011069 regeneration method Methods 0.000 description 18
- 230000006907 apoptotic process Effects 0.000 description 17
- 229960004261 cefotaxime Drugs 0.000 description 17
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 238000010438 heat treatment Methods 0.000 description 16
- 239000007788 liquid Substances 0.000 description 16
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 14
- 229930006000 Sucrose Natural products 0.000 description 14
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 14
- 239000005720 sucrose Substances 0.000 description 14
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 13
- 235000010469 Glycine max Nutrition 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 108020004707 nucleic acids Proteins 0.000 description 13
- 102000039446 nucleic acids Human genes 0.000 description 13
- 150000007523 nucleic acids Chemical class 0.000 description 13
- 238000003782 apoptosis assay Methods 0.000 description 12
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 12
- 230000005522 programmed cell death Effects 0.000 description 12
- 238000003860 storage Methods 0.000 description 12
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 10
- 244000068988 Glycine max Species 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 230000034994 death Effects 0.000 description 9
- 229920000936 Agarose Polymers 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 238000004520 electroporation Methods 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- HSSBORCLYSCBJR-UHFFFAOYSA-N Chloramben Chemical compound NC1=CC(Cl)=CC(C(O)=O)=C1Cl HSSBORCLYSCBJR-UHFFFAOYSA-N 0.000 description 7
- 244000061176 Nicotiana tabacum Species 0.000 description 7
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 230000004083 survival effect Effects 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 230000000692 anti-sense effect Effects 0.000 description 6
- 229940041514 candida albicans extract Drugs 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 239000012138 yeast extract Substances 0.000 description 6
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- 108010067770 Endopeptidase K Proteins 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 230000002424 anti-apoptotic effect Effects 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- WWAABJGNHFGXSJ-UHFFFAOYSA-N chlorophenol red Chemical compound C1=C(Cl)C(O)=CC=C1C1(C=2C=C(Cl)C(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 WWAABJGNHFGXSJ-UHFFFAOYSA-N 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 108010083942 mannopine synthase Proteins 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000001338 necrotic effect Effects 0.000 description 5
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- -1 silver nitrate Chemical class 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000001018 virulence Effects 0.000 description 5
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 4
- USGUVNUTPWXWBA-JRIXXDKMSA-N (e,2s)-2-amino-4-(2-aminoethoxy)but-3-enoic acid Chemical compound NCCO\C=C\[C@H](N)C(O)=O USGUVNUTPWXWBA-JRIXXDKMSA-N 0.000 description 4
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 210000004102 animal cell Anatomy 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000004009 herbicide Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 230000010152 pollination Effects 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 3
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 3
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 108090000848 Ubiquitin Proteins 0.000 description 3
- 102000044159 Ubiquitin Human genes 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000002363 herbicidal effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011859 microparticle Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000013638 trimer Substances 0.000 description 3
- 241000701447 unidentified baculovirus Species 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 2
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 101100442689 Caenorhabditis elegans hdl-1 gene Proteins 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- 101100399765 Escherichia coli (strain K12) lpxC gene Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- ZSILVJLXKHGNPL-UHFFFAOYSA-L S(=S)(=O)([O-])[O-].[Ag+2] Chemical compound S(=S)(=O)([O-])[O-].[Ag+2] ZSILVJLXKHGNPL-UHFFFAOYSA-L 0.000 description 2
- 108700025695 Suppressor Genes Proteins 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 108010045649 agarase Proteins 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001640 apoptogenic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000001868 cobalt Chemical class 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229960003964 deoxycholic acid Drugs 0.000 description 2
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004660 morphological change Effects 0.000 description 2
- SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 description 2
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- QNDVLZJODHBUFM-WFXQOWMNSA-N okadaic acid Chemical compound C([C@H](O1)[C@H](C)/C=C/[C@H]2CC[C@@]3(CC[C@H]4O[C@@H](C([C@@H](O)[C@@H]4O3)=C)[C@@H](O)C[C@H](C)[C@@H]3[C@@H](CC[C@@]4(OCCCC4)O3)C)O2)C(C)=C[C@]21O[C@H](C[C@@](C)(O)C(O)=O)CC[C@H]2O QNDVLZJODHBUFM-WFXQOWMNSA-N 0.000 description 2
- VEFJHAYOIAAXEU-UHFFFAOYSA-N okadaic acid Natural products CC(CC(O)C1OC2CCC3(CCC(O3)C=CC(C)C4CC(=CC5(OC(CC(C)(O)C(=O)O)CCC5O)O4)C)OC2C(O)C1C)C6OC7(CCCCO7)CCC6C VEFJHAYOIAAXEU-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 2
- QJBZDBLBQWFTPZ-UHFFFAOYSA-N pyrrolnitrin Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl QJBZDBLBQWFTPZ-UHFFFAOYSA-N 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 2
- 241000894007 species Species 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 230000005740 tumor formation Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- BLKPFVWYBFDTPX-UHFFFAOYSA-N 2-(6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)acetaldehyde Chemical compound C1C2C(C)(C)C1CC=C2CC=O BLKPFVWYBFDTPX-UHFFFAOYSA-N 0.000 description 1
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 102000011727 Caspases Human genes 0.000 description 1
- 108010076667 Caspases Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- LMKYZBGVKHTLTN-NKWVEPMBSA-N D-nopaline Chemical compound NC(=N)NCCC[C@@H](C(O)=O)N[C@@H](C(O)=O)CCC(O)=O LMKYZBGVKHTLTN-NKWVEPMBSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 102000003844 DNA helicases Human genes 0.000 description 1
- 108090000133 DNA helicases Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 101001003194 Eleusine coracana Alpha-amylase/trypsin inhibitor Proteins 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101001091269 Escherichia coli Hygromycin-B 4-O-kinase Proteins 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 241001441754 Heteralocha acutirostris Species 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010047956 Nucleosomes Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 240000008607 Opuntia megacantha Species 0.000 description 1
- 235000002840 Opuntia megacantha Nutrition 0.000 description 1
- 235000006538 Opuntia tuna Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000527181 Sisor Species 0.000 description 1
- 101001091268 Streptomyces hygroscopicus Hygromycin-B 7''-O-kinase Proteins 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 101100284789 Trichormus variabilis (strain ATCC 29413 / PCC 7937) hesA1 gene Proteins 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 230000005735 apoptotic response Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 101150014207 bag gene Proteins 0.000 description 1
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008618 cell wall macromolecule catabolic process Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 230000010428 chromatin condensation Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 230000032692 embryo implantation Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000952 necrogenic effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 210000001623 nucleosome Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 101150113864 pat gene Proteins 0.000 description 1
- 238000002205 phenol-chloroform extraction Methods 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229960002132 pyrrolnitrin Drugs 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000002786 root growth Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 101150054071 vas2 gene Proteins 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Botany (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86786997A | 1997-06-02 | 1997-06-02 | |
| PCT/EP1998/003215 WO1998054961A2 (en) | 1997-06-02 | 1998-05-29 | Plant transformation methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA72443C2 true UA72443C2 (uk) | 2005-03-15 |
Family
ID=25350632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA99126545A UA72443C2 (uk) | 1997-06-02 | 1998-05-29 | Спосіб трансформації рослин і лінія клітин ембріогенного калюсу zea mays |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0986299B1 (enExample) |
| JP (1) | JP2002502252A (enExample) |
| KR (1) | KR100505910B1 (enExample) |
| CN (1) | CN1150320C (enExample) |
| AR (1) | AR015837A1 (enExample) |
| AT (1) | ATE336890T1 (enExample) |
| AU (1) | AU735472B2 (enExample) |
| BR (2) | BRPI9816263B1 (enExample) |
| CA (1) | CA2290863C (enExample) |
| DE (1) | DE69835672T2 (enExample) |
| HU (1) | HU226212B1 (enExample) |
| IL (2) | IL132768A0 (enExample) |
| MX (1) | MX257801B (enExample) |
| PL (1) | PL336979A1 (enExample) |
| RU (1) | RU2226549C2 (enExample) |
| TR (2) | TR199902941T2 (enExample) |
| UA (1) | UA72443C2 (enExample) |
| WO (1) | WO1998054961A2 (enExample) |
| ZA (1) | ZA984681B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3331367B2 (ja) | 1997-03-11 | 2002-10-07 | 独立行政法人農業生物資源研究所 | 細胞死抑制遺伝子が導入されたストレス抵抗性植物およびその作出方法 |
| JP2002538769A (ja) * | 1998-10-30 | 2002-11-19 | ユニバーシティ オブ ネブラスカ−リンカーン | アポトーシス遺伝子の異種間移入及びそれにより開発されたトランスジェニック植物 |
| US6603061B1 (en) | 1999-07-29 | 2003-08-05 | Monsanto Company | Agrobacterium-mediated plant transformation method |
| WO2001044459A2 (en) * | 1999-12-15 | 2001-06-21 | Regents Of The University Of Minnesota | Method to enhance agrobacterium-mediated transformation of plants |
| US6570069B1 (en) * | 2000-02-10 | 2003-05-27 | Regents Of The University Of California | Nucleic acids encoding plant inhibitors of apoptosis and transgenic cells and plants expressing them |
| US7468475B2 (en) | 2000-06-16 | 2008-12-23 | Schmuelling Thomas | Method for modifying plant morphology, biochemistry and physiology |
| CN1273604C (zh) * | 2000-08-03 | 2006-09-06 | 日本烟草产业株式会社 | 提高植物细胞转基因效率的方法 |
| EP2298919A1 (en) | 2003-04-11 | 2011-03-23 | CropDesign N.V. | Method to increase stress tolerance in plants |
| KR100671225B1 (ko) | 2005-01-06 | 2007-01-19 | 전남대학교산학협력단 | 글리신-풍부 ｒｎａ-결합 단백질을 암호화하는뉴클레오타이드 서열을 이용하여 식물에 저온 또는 동결내성을 부여하는 방법 |
| GB0525645D0 (en) * | 2005-12-16 | 2006-01-25 | Plant Bioscience Ltd | Methods, means and compositions for enhancing agrobacterium-mediated plant cell transformation efficiency |
| CN100370016C (zh) * | 2006-04-21 | 2008-02-20 | 贵州大学 | 对根癌农杆菌有抑制作用的黑曲霉菌株及其用途 |
| PL2121935T3 (pl) | 2006-09-25 | 2011-12-30 | Schmuelling Thomas | Transkrypcyjne represory szlaków sygnałowych cytokinin i ich zastosowanie |
| JP2011120478A (ja) * | 2008-03-31 | 2011-06-23 | Japan Tobacco Inc | アグロバクテリウム菌による形質転換植物の作成方法 |
| AU2010278126B2 (en) | 2009-07-29 | 2015-01-22 | Kaneka Corporation | A method of gene introduction into triticum plant using agrobacterium, and a method of producing transformed triticum plant |
| CA2805263A1 (en) * | 2010-07-29 | 2012-02-02 | Dow Agrosciences Llc | Strains of agrobacterium modified to increase plant transformation frequency |
| JP2013212051A (ja) | 2010-07-29 | 2013-10-17 | Japan Tobacco Inc | アグロバクテリウム菌を用いた、オオムギ属植物へ遺伝子導入を行う方法およびオオムギ属植物の形質転換植物の作成方法 |
| GB201020737D0 (en) | 2010-12-08 | 2011-01-19 | Univ Leuven Kath | Anti-oxidative stress agents |
| CA2824152C (en) * | 2011-01-17 | 2022-12-13 | Philip Morris Products S.A. | Method and system for producing a heterologous polypeptide in a nicotiana tabacum plant |
| DE102013020605A1 (de) | 2013-12-15 | 2015-06-18 | Kws Saat Ag | Selektionsmarker-freies rhizobiaceae-vermitteltes verfahren zur herstellung einer transgenen pflanze der gattung triticum |
| BR102014023930A2 (pt) | 2014-09-26 | 2016-05-17 | Ctc Ct De Tecnologia Canavieira S A | método para transformar uma célula de planta ou tecido de planta usando agrobacterium, planta transgênica, célula transgênica ou tecido transgênico, meio de cultura, e, uso de um método para transformar uma célula de planta ou tecido de planta |
| CN116577307B (zh) * | 2023-05-16 | 2025-09-09 | 重庆极泽生物科技有限公司 | 一种基于浊度检测的禽胆汁固体物质的测量方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5380831A (en) | 1986-04-04 | 1995-01-10 | Mycogen Plant Science, Inc. | Synthetic insecticidal crystal protein gene |
| US5610042A (en) | 1991-10-07 | 1997-03-11 | Ciba-Geigy Corporation | Methods for stable transformation of wheat |
-
1998
- 1998-02-18 MX MX9911116A patent/MX257801B/es active IP Right Grant
- 1998-05-29 CN CNB988056291A patent/CN1150320C/zh not_active Expired - Lifetime
- 1998-05-29 BR BRPI9816263A patent/BRPI9816263B1/pt not_active IP Right Cessation
- 1998-05-29 KR KR19997011305A patent/KR100505910B1/ko not_active Expired - Fee Related
- 1998-05-29 UA UA99126545A patent/UA72443C2/uk unknown
- 1998-05-29 BR BRPI9809899A patent/BRPI9809899B8/pt not_active IP Right Cessation
- 1998-05-29 AT AT98936297T patent/ATE336890T1/de not_active IP Right Cessation
- 1998-05-29 AR ARP980102541A patent/AR015837A1/es active IP Right Grant
- 1998-05-29 HU HU0002903A patent/HU226212B1/hu not_active IP Right Cessation
- 1998-05-29 IL IL13276898A patent/IL132768A0/xx active IP Right Grant
- 1998-05-29 AU AU85355/98A patent/AU735472B2/en not_active Expired
- 1998-05-29 TR TR1999/02941T patent/TR199902941T2/xx unknown
- 1998-05-29 EP EP98936297A patent/EP0986299B1/en not_active Expired - Lifetime
- 1998-05-29 CA CA002290863A patent/CA2290863C/en not_active Expired - Lifetime
- 1998-05-29 JP JP50145199A patent/JP2002502252A/ja not_active Ceased
- 1998-05-29 RU RU2000100039/13A patent/RU2226549C2/ru active
- 1998-05-29 PL PL98336979A patent/PL336979A1/xx not_active IP Right Cessation
- 1998-05-29 WO PCT/EP1998/003215 patent/WO1998054961A2/en not_active Ceased
- 1998-05-29 DE DE69835672T patent/DE69835672T2/de not_active Expired - Lifetime
- 1998-05-29 TR TR2004/02566T patent/TR200402566T2/xx unknown
- 1998-06-01 ZA ZA984681A patent/ZA984681B/xx unknown
-
1999
- 1999-11-04 IL IL132768A patent/IL132768A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69835672D1 (de) | 2006-10-05 |
| TR199902941T2 (xx) | 2000-08-21 |
| AU735472B2 (en) | 2001-07-12 |
| EP0986299B1 (en) | 2006-08-23 |
| BR9809899B1 (pt) | 2013-03-19 |
| PL336979A1 (en) | 2000-07-31 |
| DE69835672T2 (de) | 2007-08-16 |
| CA2290863A1 (en) | 1998-12-10 |
| HU226212B1 (en) | 2008-06-30 |
| ZA984681B (en) | 1998-12-02 |
| WO1998054961A2 (en) | 1998-12-10 |
| IL132768A (en) | 2007-06-17 |
| CN1258316A (zh) | 2000-06-28 |
| IL132768A0 (en) | 2001-03-19 |
| AU8535598A (en) | 1998-12-21 |
| BRPI9809899B8 (pt) | 2017-03-07 |
| MX9911116A (en) | 2000-03-31 |
| KR20010013310A (ko) | 2001-02-26 |
| ATE336890T1 (de) | 2006-09-15 |
| JP2002502252A (ja) | 2002-01-22 |
| CA2290863C (en) | 2008-09-23 |
| BRPI9816263B1 (pt) | 2016-08-16 |
| MX257801B (en) | 2008-06-10 |
| KR100505910B1 (ko) | 2005-08-04 |
| CN1150320C (zh) | 2004-05-19 |
| AR015837A1 (es) | 2001-05-30 |
| WO1998054961A3 (en) | 1999-03-04 |
| TR200402566T2 (tr) | 2004-11-22 |
| BR9809899A (pt) | 2000-10-17 |
| EP0986299A2 (en) | 2000-03-22 |
| HUP0002903A3 (en) | 2002-08-28 |
| HUP0002903A2 (hu) | 2000-12-28 |
| RU2226549C2 (ru) | 2004-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA72443C2 (uk) | Спосіб трансформації рослин і лінія клітин ембріогенного калюсу zea mays | |
| US6162965A (en) | Plant transformation methods | |
| Crespi et al. | enod40, a gene expressed during nodule organogenesis, codes for a non‐translatable RNA involved in plant growth. | |
| Kalunke et al. | Agrobacterium mediated transformation of sugarcane for borer resistance using cry 1Aa 3 gene and one-step regeneration of transgenic plants | |
| Song et al. | Stable and efficient agrobacterium-mediated genetic transformation of larch using embryogenic callus | |
| Maghuly et al. | Molecular characterization of grapevine plants transformed with GFLV resistance genes: II | |
| Charity et al. | Consistent and stable expression of the npt II, uid A and bar genes in transgenic Pinus radiata after Agrobacterium tumefaciens-mediated transformation using nurse cultures | |
| KR20220031927A (ko) | 대두 식물 dbn8002를 검출하기 위한 핵산 서열 및 이의 검출 방법 | |
| EA001039B1 (ru) | Способ интеграции экзогенной днк в геном растительной клетки и способ получения фертильного трансгенного растения с интегрированной в геном экзогенной днк | |
| Raji et al. | Multiple fungal diseases resistance induction in Cucumis melo through co-transformation of different pathogenesis related (PR) protein genes | |
| Namuddu et al. | Agrobacterium mediated transformation of banana (Musa sp.) cv. Sukali Ndiizi (ABB) with a modified Carica papaya cystatin (CpCYS) gene | |
| Kaur et al. | A robust genetic transformation protocol to obtain transgenic shoots of Solanum tuberosum L. cultivar ‘Kufri Chipsona 1’ | |
| Zhu et al. | Enhancing disease resistances of super hybrid rice with four antifungal genes | |
| Ntui et al. | An efficient Agrobacterium tumefaciens-mediated genetic transformation of “Egusi” melon (Colocynthis citrullus L.) | |
| Padmanabhan et al. | Genetic transformation and regeneration of Sesbania drummondii using cotyledonary nodes | |
| Zerbini et al. | Transgenic plants | |
| Li et al. | Expression of foreign genes, GUS and hygromycin resistance, in the halophyte Kosteletzkya virginica in response to bombardment with the Particle Inflow Gun | |
| Sefasi et al. | Transient expression of β-glucuronidase in recalcitrant ugandan sweetpotato and putative transformation with two cry genes | |
| US20020088029A1 (en) | Plant transformation methods | |
| Neumann et al. | Genetic problems and gene technology | |
| Danilova et al. | A novel efficient method for maize genetic transformation: usage of agrobacterial monolayer | |
| CN119242653B (zh) | 植物抗病基因及提高植物抗病方法和应用 | |
| Huang et al. | Virulence of Agrobacterium on Larix decidua and their cellular interactions as depicted by scanning electron microscopy | |
| Park et al. | Agrobacterium-mediated genetic transformation of Chinese foxglove, Rehmannia glutinosa L. | |
| CN104388421B (zh) | 转基因水稻品系134Bt的外源插入片段旁侧序列、其扩增引物及其应用 |